Bio Key International Inc (BKYI) stock
Close on Nov 18, 2026Market cap $2.86MP/E –Yield –
Earnings
Bio Key International's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Bio Key International's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 3, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026before the open | $1.48M | -4.3% | -$4.01 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 14, 2026before the open | $1.92M | +13.1% | -$0.56 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 18, 2026before the open | $2.15M | +33.5% | -$0.15 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 4, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 14, 2025before the open | $1.55M | -26.2% | -$0.15 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | $1.70M | +54.3% | -$0.20 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025after the close | $1.61M | -26.9% | -$0.16 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 27, 2025before the open | $1.46M | – | -$0.53 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 15, 2024before the open | $2.10M | +16.7% | -$0.39 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 15, 2024after the close | $1.10M | -42.1% | -$1.00 | Release |
| Q1 FY2024ended Mar 31, 2024 | Jun 17, 2024after the close | $2.20M | -29.0% | -$0.32 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023during market hours | $1.80M | +28.6% | -$0.08 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 15, 2023before the open | $1.90M | 0.0% | -$0.16 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 16, 2023before the open | $3.10M | +59.8% | -$0.06 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 31, 2023before the open | $1.76M | +88.2% | -$0.62 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 15, 2022before the open | $1.40M | +7.7% | -$0.29 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 12, 2022before the open | $1.90M | – | -$0.21 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022before the open | $1.94M | – | -$0.12 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 29, 2022before the open | $935.00K | – | -$0.26 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 16, 2021before the open | $1.30M | – | -$0.13 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 17, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 14, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 25, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 12, 2020before the open | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 14, 2020before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Bio Key International's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenues | FY2026 | $5.00M | $5.00M | Reaffirmed | May 18, 2026 |
| revenues expected to grow | FY2026 | +50% | – | New | Apr 20, 2026 |
Guidance vs results
The last range Bio Key International gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $2.80M | $1.92M | Below range |
| Q2 FY2026 | Revenue growth | +65% | +13.15% | Below range |
| Q1 FY2026 | Revenue | $2.20M | $2.15M | Below range |
| Q1 FY2026 | Revenue growth | +37% | +33.5% | Below range |
Guidance history
Every forecast Bio Key International put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| May 18, 2026 | revenues | Q2 FY2025 | $2.80M | New |
| May 18, 2026 | revenues | FY2026 | $5.00M | Reaffirmed |
| Apr 20, 2026 | revenues expected to grow | Q1 FY2026 | +37% | New |
| Apr 20, 2026 | revenues | Q1 FY2026 | $2.20M | New |
| Apr 20, 2026 | revenues expected to grow | Q2 FY2026 | +65% | New |
| Apr 20, 2026 | revenues | Q2 FY2026 | $2.80M | New |
| Apr 20, 2026 | revenues expected to grow | FY2026 | +50% | New |
| Apr 20, 2026 | revenues | FY2026 | $5.00M | New |
| Nov 14, 2025 | full year revenue | FY2025 | $6.50M – $7.00M | New |
| Nov 15, 2024 | revenues | FY2024 | $7.75M | New |
| Nov 15, 2022 | full-year revenues | FY2022 | $7.00M – $9.00M | Lowered |
| Aug 12, 2022 | revenue guidance | FY2022 | $10.00M – $13.00M | Reaffirmed |
| May 16, 2022 | revenue guidance | FY2022 | $10.00M – $13.00M | Reaffirmed |
| Mar 29, 2022 | revenue guidance | FY2022 | $10.00M – $13.00M | New |
| Nov 16, 2021 | revenue | FY2021 | $5.50M – $7.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Bio Key International filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Update
- News
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?